Abstract Title:

Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer.

Abstract Source:

Cancer Lett. 2008 Jan 18;259(1):39-49. Epub 2007 Oct 29. PMID: 17967505

Abstract Author(s):

Sang Hyub Lee, Ji Kon Ryu, Kyeung-Yeup Lee, Sang Myung Woo, Joo Kyung Park, Ji Won Yoo, Yong-Tae Kim, Yong Bum Yoon

Article Affiliation:

Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 110-744, Yeongeon-dong 28, Jongno-gu, Seoul, Republic of Korea.

Abstract:

Apigenin is a dietary flavonoid possessing therapeutic potential against cancers. This study was designed to investigate whether combination therapy with gemcitabine and apigenin enhanced anti-tumor efficacy in pancreatic cancer. In vitro, the combination treatment resulted in more growth inhibition and apoptosis through the down-regulation of NF-kappa B activity with suppression of Akt activation in pancreatic cancer cell lines (MiaPaca-2, AsPC-1). In vivo, the combination therapy augmented tumor growth inhibition through the down-regulation of NF-kappa B activity with the suppression of Akt in tumor tissue. The combination of gemcitabine and apigenin enhanced anti-tumor efficacy through Akt and NF-kappa B activity suppression and apoptosis induction.

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.